117 related articles for article (PubMed ID: 34475084)
1. Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma.
Kawasaki M; Sakabe T; Kodani I; Umekita Y
Anticancer Res; 2021 Sep; 41(9):4563-4570. PubMed ID: 34475084
[TBL] [Abstract][Full Text] [Related]
2. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
[TBL] [Abstract][Full Text] [Related]
4. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas.
Takeda C; Takagi Y; Shiomi T; Nosaka K; Yamashita H; Osaki M; Endo K; Minamizaki T; Teshima R; Nagashima H; Umekita Y
Diagn Pathol; 2014 Oct; 9():205. PubMed ID: 25358722
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic-only Expression of Maspin Predicts Unfavorable Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Uchinaka EI; Sakabe T; Hanaki T; Tokuyasu N; Sakamoto T; Honjo S; Fujiwara Y; Umekita Y
Anticancer Res; 2021 May; 41(5):2543-2552. PubMed ID: 33952482
[TBL] [Abstract][Full Text] [Related]
8. Maspin expression in oral squamous cell carcinoma.
Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
[TBL] [Abstract][Full Text] [Related]
9. [Mammary serine proteinase inhibitor subcellular expression in oral squamous cell carcinoma and its clinical significance].
Luo J; Shu HR; Ying YK; Wu WL; Ji T; Zhong LP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):505-9. PubMed ID: 22169751
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm.
Takagi Y; Matsuoka Y; Shiomi T; Nosaka K; Takeda C; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
Histopathology; 2015 Apr; 66(5):732-9. PubMed ID: 25322663
[TBL] [Abstract][Full Text] [Related]
12. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cytoplasmic p27 in oral squamous cell carcinoma.
Vallonthaiel AG; Singh MK; Dinda AK; Kakkar A; Thakar A; Das SN
J Oral Pathol Med; 2016 Aug; 45(7):475-80. PubMed ID: 26750594
[TBL] [Abstract][Full Text] [Related]
15. Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
Harada Y; Izumi H; Noguchi H; Kuma A; Kawatsu Y; Kimura T; Kitada S; Uramoto H; Wang KY; Sasaguri Y; Hijioka H; Miyawaki A; Oya R; Nakayama T; Kohno K; Yamada S
Tumour Biol; 2016 Jan; 37(1):1357-68. PubMed ID: 26296622
[TBL] [Abstract][Full Text] [Related]
16. Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
Wakahara M; Sakabe T; Kubouchi Y; Hosoya K; Hirooka Y; Yurugi Y; Nosaka K; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Sep; 37(9):5071-5077. PubMed ID: 28870936
[TBL] [Abstract][Full Text] [Related]
17. [Expression of mammary serine proteinase inhibitor in oral squamous cell carcinoma and its clinical significance].
Luo J; Zhou L; Zheng GJ; Ji T; Zhong LP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Oct; 44(10):606-10. PubMed ID: 20079307
[TBL] [Abstract][Full Text] [Related]
18. Expression of the tumour-suppressor maspin in temporal bone carcinoma.
Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A
Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906
[TBL] [Abstract][Full Text] [Related]
19. [The expression of Maspin and VEGF gene in oral squamous cell carcinoma and its significance].
Zhang L; Tang ZG; Zhou ZG; Tong XJ; Li XL
Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):557-60. PubMed ID: 16400477
[TBL] [Abstract][Full Text] [Related]
20. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma.
Xia W; Lau YK; Hu MC; Li L; Johnston DA; Sheng Sj; El-Naggar A; Hung MC
Oncogene; 2000 May; 19(20):2398-403. PubMed ID: 10828881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
